| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Cell |
| Molecule Category: | UNKNOWN |
| UNII: | G3NJ7M8N4H |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | The T-cell receptor recognises an EBV peptide in complex with a specific HLA molecule on the surface of target cells to exert cytotoxic activity |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 2 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3990008 |
| FDA SRS | G3NJ7M8N4H |
CONTENTS